Research Update Jan. 10, 2024 Decades of research supported by NIDDK and other NIH Institutes recently led to the landmark U.S. Food and Drug Administration (FDA) approval of…
A man with type 1 diabetes became the first patient to produce his own insulin after undergoing genetically engineered cell transplants, without the need for drugs to prevent rejection. Published…
This week's issue of The Savvy Diabetic: 3D printed islet transplantation Abvance therapy funded for next-generation glucagon analogs/therapies Glucotrack's CBGM Implant Technology The AX-4 Space Mission Study Glucose Metabolism and…
Sana Biotechnology Announces Positive Clinical Results in Type 1 Diabetes Study of Pancreatic Islet Cell Transplantation Without Immunosuppression Released by Sana.com on January 7, 2025. Sana Biotechnology, Inc., a company…